The PE Ratio as of November 2024 (TTM) for Novartis AG (NVSEF) is 18.15

According to Novartis AG’s latest financial reports and current stock price. The company's current PE Ratio is 18.15. This represents a change of 25.01% compared to the average of 14.52 of the last 4 quarters.

Novartis AG (NVSEF) Historical PE Ratio (quarterly & annually)

How has NVSEF PE Ratio performed in the past?

The mean historical PE Ratio of Novartis AG over the last ten years is 19.25. The current 18.15 PE Ratio has changed 9.33% with respect to the historical average. Over the past ten years (40 quarters), NVSEF's PE Ratio was at its highest in in the December 2015 quarter at 49.22. The PE Ratio was at its lowest in in the December 2021 quarter at 2.84.

Novartis AG (NVSEF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Novartis AG PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Novartis AG (NVSEF) Average PE Ratio

How has NVSEF PE Ratio performed in the past?

The current PE Ratio of Novartis AG (NVSEF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Novartis AG (NVSEF) PE Ratio vs. Peers

How is NVSEF’s PE Ratio compared to its peers?

Novartis AG’s PE Ratio is greater than Roche Holding AG (16.14), less than AstraZeneca PLC (31.96), greater than Roche Holding AG (15.77), greater than Sanofi (8.31), greater than Bristol-Myers Squibb Company PFD CONV 2 (-280.97), less than Astellas Pharma Inc. (0), less than Roche Holding AG (154.76), greater than Scilex Holding Company (16.07), greater than Novartis AG (-0.53), greater than AstraZeneca PLC (11.92), less than GSK plc (31.32), less than Bayer Aktiengesellschaft (22.01), greater than Organon & Co. (-5.52), greater than Horizon Therapeutics Public Limited Company (3.02), less than null (51.10),

Build a custom stock screener for Novartis AG (NVSEF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novartis AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Novartis AG (NVSEF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Novartis AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.